Former RediClinic executive to speak at 2009 Health Technology Investment Forum

NEW YORK Former RediClinic executive Christopher Kersey is scheduled to speak about the future of health care at the 2009 Health Technology Investment Forum in September.

Kersey, former chief business development officer and chief medical officer of RediClinic, will join David Farber, JD, of Patton Boggs to address in their presentation entitled, “The Future of Healthcare: Unique Perspectives from the Investor and Policy Maker,” both the political forces shaping healthcare reform and the future of healthcare. Other topics that will be discussed include: substantive proposed changes affecting the healthcare industry, fee-for-service or bundled payments, and the most effective business models post-healthcare reform.

The forum, to be held Sept. 22, will attract such attendees as private equity firms, venture capital groups, corporate development teams, institutional investors and CEOs from healthcare technology companies.

Kersey, who currently works for Camden Partners, began his career as an associate at Menlo Ventures where he focused on healthcare and life science investments. He gained operational experience as the chief business development officer and chief medical officer of RediClinic. Prior to joining Camden Partners in 2008, he served as a managing director of Cogene Ventures.